
Holly Liptak
Articles
-
1 month ago |
healio.com | W. Clark |Holly Liptak |Christine Klimanskis
KOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2025, W. Lloyd Clark, MD, discusses the use of aflibercept 8 mg in the treatment of retinal vein occlusion. Clinical trial data support the use of higher-dose VEGF inhibition, he said. “I’m very excited about these clinical trial results, and as we move forward into 2025, I’m hopeful that we’ll have this treatment option available to us to improve clinical outcomes with retinal vein occlusion,” Clark said.
-
1 month ago |
healio.com | Holly Liptak |Roger A. Goldberg |Christine Klimanskis
KOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2025, Roger A. Goldberg, MD, MBA, highlights advancements in the treatment of retinal vein occlusion. Goldberg discussed the FDA approval of Vabysmo (faricimab, Genentech) for the treatment of retinal vein occlusion (RVO) and the possible label expansion of high-dose aflibercept for the treatment of RVO in the coming year. “Retinal vein occlusion is kind of the forgotten stepchild of retinal vascular diseases,” Goldberg said.
-
Dec 20, 2024 |
healio.com | Holly Liptak
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Healio spoke with Ahmad Anouti, MD, about a presentation at The Liver Meeting on the prognostic value of reaching normal bilirubin levels after Kasai portoenterostomy in biliary atresia.
-
Dec 20, 2024 |
healio.com | Holly Liptak
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Dec 20, 2024 |
healio.com | Holly Liptak
You've successfully added Practice Management in Gastroenterology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →